Merck Wins Lawsuit on Levothyroxine Saga in France Merck Wins Lawsuit on Levothyroxine Saga in France
Merck has prevailed in a first lawsuit that claimed that switching the formulation of levothyroxine in France caused patients harm. The company still faces further claims, however.Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
More News: Diabetes | Endocrinology | France Health | Health | Lawsuits | Legislation | Levothyroxine | Merck | Synthroid